Endothelial cells and magnesium: Implications in atherosclerosis

Clinical Science

Volumn 122, Issue 9, 2012, Pages 397-407

  Maier, Jeanette A M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; Endothelial cell; Inflammation; Magnesium; Oxidative stress; Thrombosis

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 ANTIBODY; LOW DENSITY LIPOPROTEIN; MAGNESIUM; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; INTERLEUKIN 1ALPHA; PEPTIDE HYDROLASE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DISEASE COURSE; DNA DAMAGE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOMAGNESEMIA; IN VITRO STUDY; INSULIN RESISTANCE; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; MAGNESIUM DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CAPILLARY PERMEABILITY; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOSIS;

ANIMALS; ATHEROSCLEROSIS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1ALPHA; MAGNESIUM; MAGNESIUM DEFICIENCY; MODELS, CARDIOVASCULAR; NF-KAPPA B; OXIDATIVE STRESS; PEPTIDE HYDROLASES; THROMBOSIS;

EID: 84857699742     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110506     Document Type: Review

References (96)

1. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695
2. Libby, P., Okamoto, Y., Rocha, V. Z. and Folco, E. (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74, 213-220
3. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B. et al. (2006) Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler. Thromb. Vasc. Biol. 26, 2186-2191
4. Wolf, F. I. and Trapani, V. (2008) Cell (patho)physiology of magnesium. Clin. Sci. 114, 27-35
5. Ford, E. S. and Mokdad, A. H. (2003) Dietary magnesium intake in a national sample of US adults. J. Nutr. 133, 2879-2882
6. Romani, A. M. (2011) Cellular magnesium homeostasis. Arch. Biochem. Biophys. 512, 1-23
7. Ford, E. S. (1999) Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int. J. Epidemiol. 28, 645-651
8. Khan, A. M., Sullivan, L., McCabe, E., Levy, D., Vasan, R. S. and Wang, T. J. (2010) Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am. Heart J. 160, 715-720
9. Resnick, L. M., Altura, B. T., Gupta, R. K., Laragh, J. H., Alderman, M. H. and Altura, B. M. (1993) Intracellular and extracellular magnesium depletion in type 2 (non-insulindependent) diabetes mellitus. Diabetologia 36, 767-770
10. Fletcher, G. F., Sweeney, M. E. and Fletcher, B. J. (1991) Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of β-adrenergic blockade. Am. Heart J. 121, 105-110
11. Ma, J., Folsom, A. R., Melnick, S. L., Eckfeldt, J. H., Sharrett, A. R., Nabulsi, A. A., Hutchinson, R. G. and Metcalf, P. A. (1995) Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. J. Clin. Epidemiol. 48, 927-940
12. Leone, N., Courbon, D., Ducimetiere, P. and ZureiK, M. (2006) Zinc, copper and magnesium and risk for all-causes, cancer and cardiovascular mortality. Epidemiology 17, 308-314
13. Turgut, F., Kanbay, M., Metin, M. R., Uz, E., Akcay, A. and Covic, A. (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int. Urol. Nephrol. 40, 1075-1082
14. Van Laecke, S., Maréchal, C., Verbeke, F., Peeters, P., Van Biesen, W., Devuyst, O., Jadoul, M. and Vanholder, R. (2011) The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrol. Dial. Transplant. 26, 2362-2369
15. Al-Delaimy, W. K., Rimm, E. B., Willettm, W. C., Stampfer, M. J. and Hu, F. B. (2004) Magnesium intake and risk of coronary heart disease among men. J. Am. Coll. Nutr. 23, 63-70
16. Abbott, R. D., Ando, F., Masaki, K. H., Tung, K. H., Rodriguez, B. L., Petrovitch, H., Yano, K. and Curb, J. D. (2003) Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am. J. Cardiol. 92, 665-669
17. Barbagallo, M. and Dominguez, L. J. (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 458, 40-47
18. Rayssiguier, Y., Noé, L., Etienne, J., Gueux, E., Cardot, P. and Mazur, A. (1991) Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat. Lipids 26, 182-186
19. Rosanoff, A. and Seelig, M. S. (2004) Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J. Am. Coll. Nutr. 23, 501S-505S
20. Kishimoto, Y., Tani, M., Uto-Kondo, H., Saita, E., Iizuka, M., Sone, H., Yokota, K. and Kondo, K. (2010) Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br. J. Nutr. 103, 469-472
21. Guerrero-Romero, F. and Rodríguez-Morán, M. (2006) Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab. Res. Rev. 22, 471-476
22. Bubici, C., Papa, S., Dean, K. and Franzoso, G. (2006) Mutual cross-talk between reactive oxygen species and NF-κB: molecular basis and biological significance. Oncogene 25, 6731-6748
23. Song, Y., Li, T. Y., van Dam, R. M., Manson, J. E. and Hu, F. B. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am. J. Clin. Nutr. 85, 1068-1074
24. Chacko, S. A., Song, Y., Nathan, L., Tinker, L., de Boer, I. H., Tylavsky, F., Wallace, R. and Liu, S. (2010) Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 33, 304-310
25. Kim, D. J., Xun, P., Liu, K., Loria, C., Yokota, K., Jacobs, Jr, D. R. and He, K. (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33, 2604-2610
26. Maier, J. A. (2003) Low magnesium and atherosclerosis: an evidence-based link. Mol. Aspects Med. 24, 137-146
27. Mazur, A., Maier, J. A., Rock, E., Gueux, E., Nowacki, W. and Rayssiguier, Y. (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch. Biochem. Biophys. 458, 48-56
28. Steinberg, D. (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8, 1211-1217
29. Galley, H. and Webster, N. (2004) Physiology of the endothelium. Br. J. Anaest. 93, 105-130
30. Widlansky, M. E., Gokce, N., Keaney, Jr, J. F. and Vita, J. A. (2003) The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 42, 1149-1160
31. Vanhoutte, P. M. (2009) Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ. J. 73, 595-601
32. Versari, D., Daghini, E., Virdis, A., Ghiadoni, L. and Taddei, S. (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 32, S314-S321
33. Davignon, J. and Ganz, P. (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 23 (Suppl. 1), III27-III32
34. Shechter, M. (2010) Magnesium and cardiovascular system. Magnes. Res. 23, 60-72
35. Shechter, M., Sharir, M., Labrador, M. J., Forrester, J., Silver, B. and Bairey Merz, C. N. (2000) Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102, 2353-2358
36. Barbagallo, M, Dominguez, L. J., Galioto, A., Pineo, A. and Belvedere, M. (2010) Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes. Res. 23, 131-137
37. Adrian, M., Chanut, E., Laurant, P., Gaume, V. and Berthelot, A. (2008) A long-term moderate magnesium-deficient diet aggravates cardiovascular risks associated with aging and increases mortality in rats. J. Hypertens. 26, 44-52
38. Paravicini, T. M., Yogi, A., Mazur, A. and Touyz, R. M. (2009) Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 53, 423-429
39. Schlingmann, K. P., Waldegger, S., Konrad, M., Chubanov, V. and Gudermann, T. (2007) TRPM6 and TRPM7: gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta 1772, 813-821
40. Inoue, K. and Xiong, Z. G. (2009) Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway. Cardiovasc. Res. 83, 547-557
41. Yoshimura, M., Oshima, T., Matsuura, H., Inoue, T., Kambe, M. and Kajiyama, G. (1997) Differential effects of extracellular Mg on thrombin-induced and capacitative Ca entry in human coronary arterial endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 3356-3361
42. Wiles, M. E., Wagner, T. L. and Weglicki, W. B. (1997) Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production. Life Sci. 60, 221-236
43. Dickens, B. F., Weglicki, W. B., Li, Y. S. and Mak, I. T. (1992) Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett. 311, 187-191
44. Hensley, K., Robinson, K. A., Gabbita, S. P., Salsman, S. and Floyd, R. A. (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radical Biol. Med. 28, 1456-1462
45. Widlansky, M. E. and Gutterman, D. D. (2011) Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid. Redox Signaling 15, 1517-1530
46. Förstermann, U. (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 5, 338-349
47. Zhou, Q., Olinescu, R. M. and Kummerow, F. A. (1999) Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells. Magnes. Res. 12, 19-29
48. Wolf, F. I., Trapani, V., Simonacci, M., Ferré, S. and Maier, J. A. (2008) Magnesium deficiency and endothelial dysfunction: is oxidative stress involved? Magnes. Res. 21, 58-64
49. Nedeljkovic, Z. S., Gokce, N. and Loscalzo, J. (2003) Mechanisms of oxidative stress and vascular dysfunction. Postgrad. Med. J. 79, 195-199
50. Xu, Q. (2002) Role of heat shock proteins in atherosclerosis. Arterioscl. Thromb. Vasc. Biol. 22, 1547-1559
51. Ravagnan, L., Gurbuxani, S., Susin, S. A., Maisse, C., Daugas, E., Zamzami, N., Mak, T., Jäättelä, M., Penninger, J. M., Garrido, C. and Kroemer, G. (2001) Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3, 839-843
52. Patterson, C. and Cyr, D. (2002)Welcome to a machine: a cardiologist's introduction to protein folding and degradation. Circulation 106, 2741-2746
53. Ferr'e, S., Mazur, A. and Maier, J. A. (2007) Low Mg induces senescent features in cultured human endothelial cells. Magnes. Res. 20, 66-71
54. Boueiz, A. and Hassoun, P. M. (2009) Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc. Res. 77, 26-34
55. Suttorp, N., Fuchs, T., Seeger, W.,Wilke, A. and Drenckhahn, D. (1989) Role of Ca and Mg for endothelial permeability of water and albumin in vitro. Lab. Invest. 61, 183-191
56. Yokoyama, S., Gu, J., Kashima, K., Nishida, H. I., Smith, T. L. and Kummerow, F. A. (1994) Combined effects of magnesium deficiency and an atherogenic level of low density lipoprotein on uptake and metabolism of low density lipoprotein by cultured human endothelial cells. II. Electron microscopic data. Magnes. Res. 7, 97-105
57. Yokoyama, S., Nishida, H. I., Smith, T. L. and Kummerow, F. A. (1994) Combined effects of magnesium deficiency and an atherogenic level of low density lipoprotein on uptake and metabolism of low density lipoprotein by cultured human endothelial cells. I. Biochemical data. Magnes. Res. 7, 87-95
58. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241
59. Ferr'e, S., Baldoli, E., Leidi, M. and Maier, J. A. (2010) Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NF-κB. Biochim. Biophys. Acta 1802, 952-958
60. de Winther, M. P.J., Kanters, E., Kraal, G. and Hofker, M. H. (2005) Nuclear factor-κB signaling in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25, 904-914
61. Rochelson, B., Dowling, O., Schwartz, N. and Metz, C. N. (2007) Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NF-κB pathway. J. Reprod. Immunol. 73, 101-107
62. Dinarello, C. A. (2010) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732
63. Hansson, G. K. and Klareskog, L. (2011) Pulling down the plug on atherosclerosis: cooling down the inflammasome. Nat. Med. 17, 790-791
64. Maier, J. A., Statuto, M. and Ragnotti, G. (1994) Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 14, 1845-1851
65. Maier, J. A., Malpuech-Brug'ere, C., Zimowska, W., Rayssiguier, Y. and Mazur, A. (2004) Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim. Biophys. Acta 1689, 13-21
66. Maier, J. A., Voulalas, P., Roeder, D. and Maciag, T. (1990) Extension of the life-span of human endothelial cells by an IL-1α antisense oligomer. Science 249, 1570-1574
67. Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H. and Komuro, I. (2002) Endothelial senescence in human atherosclerosis. Circulation 105, 1541-1546
68. Killilea, D.W. and Maier, J. A. (2008) A connection between magnesium deficiency and aging: new insights from cellular studies. Magnes. Res. 21, 77-82
69. Killilea, D.W. and Ames, B. N. (2008) Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 105, 5768-5773
70. Zernecke, A., Shagdarsuren, E. and Weber, C. (2008) Chemokines in atherosclerosis. An update. Arterioscler. Thromb. Vasc. Biol. 28, 1897-1908
71. Cook-Mills, J. M., Marchese, M. E. and Abdala-Valencia, H. (2011) Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid. Redox Signaling 15, 1607-1638
72. Kawano, H., Yokoyama, S., Smith, T. L., Nishida, H. I., Taguchi, T. and Kummerow, F. A. (1995) Effect of magnesium on secretion of platelet-derived growth factor by cultured human umbilical arterial endothelial cells. Magnes. Res. 8, 137-144
73. Khachigian, L. M., Resnick, N., Gimbrone, M. A. and Collins, T. (1995) Nuclear factor-κB interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96, 169-175
74. Funayama, H., Ikeda, U., Takahashi, M., Sakata, Y., Kitagawa, S., Takahashi, Y., Masuyama, J., Furukawa, Y., Miura, Y., Kano, S. et al. (1998) Human monocyteendothelial cell interaction induces plateletderived growth factor expression. Cardiovasc. Res. 37, 216-224
75. Barrett, T. B. and Benditt, E. P. (1987) Sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. U.S.A. 84, 1099-1103
76. Galis, Z. S., Sukhova, G. K., Lark, M.W. and Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503
77. Volcik, K. A., Campbell, S., Chambless, L. E., Coresh, J., Folsom, A. R., Mosley, T. H., Ni, H., Wagenknecht, L. E., Wasserman, B. A. and Boerwinkle, E. (2010) MMP-2 genetic variation is associated with measures of fibrous cap thickness: the Atherosclerosis Risk in Communities Carotid MRI Study. Atherosclerosis 210, 188-193
78. Pag'es, N., Gogly, B., Godeau, G., Igondjo-Tchen, S., Maurois, P., Durlach, J. and Bac, P. (2003) Structural alterations of the vascular wall in magnesium-deficient mice. A possible role of gelatinases A (MMP-2) and B (MMP-9). Magnes. Res. 16, 43-48
79. Bond, M., Chase, A. J., Baker, A. H. and Newby, A. C. (2001) Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc. Res. 50, 556-565
80. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D. G. and Tsao, P. S. (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88, 1291-1298
81. Hu, T., Luan, R., Zhang, H., Lau, W. B., Wang, Q., Zhang, Y., Wang, H. C. and Tao, L. (2009) Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 36, 626-630
82. Gurjar, M. V., Deleon, J., Sharma, R. V. and Bhalla, R. C. (2001) Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am. J. Physiol. Heart Circ. Physiol. 281, H2568-H2574
83. Mitchell, J. A., Ali, F., Bailey, L., Moreno, L. and Harrington, L. S. (2008) Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp. Physiol. 93, 141-147
84. Zhou, Q., Zhou, Y., Liu, W. and Kummerow, F. A. (2008) Low magnesium stimulated prostacyclin generation in cultured human endothelial cells. Magnes. Res. 21, 177-184
85. Belton, O., Byrne, D., Kearney, D., Leahy, A. and Fitzgerald, D. J. (2000) Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102, 840-845
86. Rock, E., Astier, C., Lab, C., Malpuech, C., Nowacki, W., Gueux, E., Mazur, A. and Rayssiguier, Y. (1995) Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 8, 237-242
87. Bernardini, D., Nasulewicz, A., Mazur, A. and Maier, J. A. (2005) Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Front. Biosci. 10, 1177-1182
88. Comi, P., Chiaramonte, R. and Maier, J. A. (1995) Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp. Cell Res. 219, 304-308
89. Robbie, L. A., Booth, N. A., Brown, A. J. and Bennett, B. (1996) Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 16, 539-545
90. Schäfer, K., Müller, K., Hecke, A., Mounier, E., Goebel, J., Loskutoff, D. J. and Konstantinides, S. (2003) Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler. Thromb. Vasc. Biol. 23, 2097-2103
91. Maier, J. A., Bernardini, D., Rayssiguier, Y. and Mazur, A. (2004) High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim. Biophys. Acta 1689, 6-12
92. Dolinsky, B. M., Ippolito, D. L., Tinnemore, D., Stallings, J. D., Zelig, C. M. and Napolitano, P. G. (2010) The effect of magnesium sulfate on the activity of matrix metalloproteinase-9 in fetal cord plasma and human umbilical vein endothelial cells. Am. J. Obstet. Gynecol. 203, 371.e1-371.e5
93. Dong, J. F., Cruz, M. A., Aboulfatova, K., Martin, C., Choi, H., Bergeron, A. L., Martini, S. R., Kroll, M. H. and Kent, T. A. (2008) Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. Thromb. Haemostasis 99, 586-593
94. Mussoni, L., Sironi, L., Tedeschi, L., Calvio, A. M., Colli, S. and Tremoli, E. (2001) Magnesium inhibits arterial thrombi after vascular injury in rat: in vivo impairment of coagulation. Thromb. Haemostasis 86, 1292-1295
95. Touyz, R. M. and Yao, G. (2003) Modulation of vascular smooth muscle cell growth by magnesium: role of mitogen-activated protein kinases. J. Cell. Physiol. 197, 326-335
96. Fadini, G. P., Agostini, C., Sartore, S. and Avogaro, A. (2007) Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194, 46-54